Maine Drug and Alcohol Inpatient Treatment Licensing

Author: A. Ant, CADC-II, Licensing & Accreditation Expert

Disclaimer: This content is provided for general informational purposes only and should not be construed as legal, regulatory, or licensing advice. Requirements change frequently. Consult qualified professionals for guidance specific to your situation.

Apply now: Substance Use Disorder Treatment Agency Initial, Renewal, and Change Application, listed on the DLC Behavioral Health Program page | Questions: BehavioralHealth.DLC@maine.gov, (207) 287-9300, Option 2

Maine wants two letters in the mail before a residential substance use disorder program files anything at all. Section 2(A)(4) of 10-144 CMR Chapter 123 says that “Prior to application, organizations intending to provide residential behavioral health services must submit letters” of notice to the Office of MaineCare Services and to the Office of Behavioral Health. Treat those letters as the first filing step of the license, because that is how the rule positions them. Next, the State Fire Marshal’s Office has to sign off on the life safety of every site, and the building itself can’t be someone’s home, since Chapter 123 won’t approve a private residence for treatment. The license that follows is issued by the Maine Department of Health and Human Services (DHHS), Division of Licensing and Certification (DLC), through its Behavioral Health Program. The state’s other program types are covered on Maine Behavioral Health Licensing.

Before the Packet Goes In

Everything in this section traces to Chapter 123, Sections 2 and 21, in the text Cornell’s Legal Information Institute reproduces.

The notice letters come first because the rule says “prior to application.” We’d send them on letterhead, describe the residential service and the site, and keep dated copies in the application file so DLC can see the sequence was followed. Beyond stating your intent to seek a license, the rule doesn’t say what the letters must contain, so the rest is our practice, not a DLC instruction.

The fire inspection runs on the same early track. Section 2(N) has the State Fire Marshal’s Office certify every site against the NFPA Life Safety Code before a license issues and again before each re-licensure. Section 21(E)(11)(a) puts it in residential terms, requiring the facility to “secure written documentation of compliance with the life safety code after an inspection by the SFMO or designee.” A site drawing from its own well has to test the water at a Maine-certified lab, then for coliform bacteria and nitrates every year. Under Section 2(I), adding residential capacity or starting new construction takes Department approval worked out with the Fire Marshal’s office, so if you plan to add beds later, we’d budget for another look at the building then.

The site has to be a facility, not a residence. Section 2(K) says a private residence cannot be approved for mental health or SUD treatment. Section 21(E)(12) won’t let a new residential license issue unless single bedrooms give the client 100 square feet of usable floor space and shared rooms give each occupant 80. Measure before you sign a lease, because a floor plan showing bedrooms is part of the residential application.

What Maine Actually Licenses Here

Maine’s statute calls the residential version of this business a “drug treatment center,” which 22 MRS §8001 defines as “a residential facility, not” “licensed as a medical care facility under chapter 405, for the care, treatment or rehabilitation” “of drug users, including alcohol users.” The modern rule is Chapter 123, the Behavioral Health Organizations Licensing Rule, which took effect February 11, 2024 and folded three older rules (including the former SUD rule, 14-118 CMR Chapter 5) into one. One rule does not mean one license, though. DLC’s Behavioral Health Program page says licenses “are not currently integrated,” so an organization offering both mental health and SUD services files separate applications and holds a separate license for each. On the SUD side, Appendix A’s residential services include a residential treatment program, provision of medication for opioid use disorders and medically supervised withdrawal programs, alongside diagnostic, educational and counseling services.

New organizations don’t start with a full license. Section 2(F) issues a provisional license “for a term of no less than three months and no more than 12 months” to an applicant that hasn’t operated as a behavioral health organization before. A full license, for two years, follows once the program shows compliance. Section 2(B) makes the license non-transferable, so a buyer of an existing program applies for its own.

Fees depend on whether you hold one service category or two. Section 3(E) prices a single category at the lower tier and “both service categories or integrated services” at the higher one. All fees are nonrefundable and paid to “Treasurer, State of Maine.”

Chapter 123 fee (Section 3(E))	SUD only	Integrated MH and SUD, or both categories
Provisional license application	$125	$250
Full license	$250	$500
Biennial renewal	$170	$340
Adding a site	$50	$50
Adding a module or program	$70	$70

ASAM Placement Without ASAM Levels on the License

Section 23(A)(1) requires SUD programs to place clients using “The ASAM Criteria,” current edition. The license itself names services, not level numbers, so nothing on a Maine license will say 3.5 or 3.7. That’s our reading of Section 23 and Appendix A, where we found no level designation. A program that wants its level verified by an outside body can pursue CARF’s ASAM Level of Care Certification, a program ASAM runs jointly with CARF and which CARF says “is available for adult Levels of Care 3.1, 3.5, and 3.7.” Maine doesn’t require it. A referral source can still confirm it through CARF’s provider search using the “ASAM Level of Care 3.7” certification filter, along with the 3.1 and 3.5 options. Neither CARF nor ASAM describes it as covering withdrawal management, so in our view it fits the residential treatment module and leaves a medically supervised withdrawal module standing on the DLC license alone.

MOUD Access in a Maine Residential Program

Chapter 123 expects access, not necessarily on-site prescribing. Section 23(H)(2) tells residential SUD programs to “promote access to all forms of MOUD,” either on site or through direct coordination with outpatient providers or referral. A residential program that also runs medically supervised withdrawal carries a firmer duty under Section 23(H)(4)(g)(v), “meaningful access to all forms of MOUD.” MOUD is also a module a residential program can hold under Appendix A, which Section 1 defines as treatment that “combines medication approved by the federal Food and Drug Administration” with counseling, substance use testing and behavioral therapy.

Methadone stays inside opioid treatment programs (Section 23(G)(4)), which Maine licenses separately for each site, so the practical step is a written arrangement with a nearby OTP for residents already dosing there. Buprenorphine is simpler than it used to be. Since a DEA letter dated January 12, 2023, “all prescriptions for buprenorphine only require a standard DEA registration number.” SAMHSA describes naltrexone as “not a controlled substance,” and any practitioner licensed to prescribe medications can prescribe it. We didn’t find a Chapter 123 clause barring admission of someone already on MOUD, though turning that person away would be hard to reconcile with the access language above.

Ketamine on a Maine Residential License

Ketamine appears nowhere in Chapter 123, and DLC hasn’t published anything on it that we could find. Everything in this section is our reading of the rule and the other sources cited, so describe your plan to the Behavioral Health Program in writing before anyone is dosed.

The question in Maine is procedural before it is clinical. Appendix A has no ketamine module, and Section 2(I) says “No new service type, module, program, facility, or site may be commenced without Department approval,” with 30 calendar days’ notice for adding a service type or module. Treating a resident’s co-occurring depression or PTSD with ketamine could count as ordinary medication management inside the residential module you already hold. DLC could see it differently. Because a wrong guess there means operating a service without approval, we’d send the 30-day notice anyway and ask DLC to say in writing which way it reads the change.

Clinical coverage is the practical test. A residential treatment module only guarantees staff coverage around the clock (Section 23(H)(3)(e)). The medically supervised withdrawal module adds a physician, NP or PA reachable by phone 24 hours a day and a nurse on site when assessments show the need (Section 23(H)(4)(f)). Neither puts a nurse beside every bed on a dosing day, so the program’s own protocol has to supply observation time after each dose.

Nursing, Prescribers and the Drug Itself

The Maine State Board of Nursing has no ketamine statement. Its April 2002 position says an RN “may not administer anesthetic medications for the purpose of anesthesia” unless a CRNA, but may “administer anesthetic agents, such as Diprivan, for the purpose of analgesia, muscle relaxation, or sedation” after “the appropriate documented training” under facility policy. Reading a sub-anesthetic depression dose into that analgesia and sedation language is our extension of the Board’s words, not something it has said.

On prescribing, a Maine nurse practitioner “must practice, for at least 24 months, under the supervision of a licensed physician or a supervising nurse practitioner” or be employed by a clinic or hospital with a licensed physician as medical director (32 MRS §2102(2-A)). Ketamine sits in federal Schedule III (21 CFR 1308.13(c)(7)), so whoever prescribes it needs a DEA registration. Maine doesn’t layer a state registration over that, and the FAQ of its Drug Enforcement Agency puts it plainly: “Maine does not require healthcare practitioners register as does the U.S. Drug Enforcement Administration.”

The Prescription Monitoring Program puts its reporting duty on dispensers, and 22 MRS §7246(2) defines a “Dispenser” as “A pharmacist who is licensed or registered under Title 32” (or a veterinarian). We read that to mean a residential program giving a dose on site isn’t itself a PMP reporter, while the pharmacy that supplied the drug reports its own dispensing. The mandatory prescriber lookup in 22 MRS §7253(1) is triggered by a benzodiazepine or opioid prescription, so by its terms it doesn’t reach ketamine. We’d still have the prescriber check a resident in the PMP before the first dose, as a matter of practice rather than law. Spravato is narrower than generic ketamine. The FDA Medication Guide says “SPRAVATO can only be administered at healthcare settings certified in the SPRAVATO REMS program,” and the provider “must monitor you for at least 2 hours after taking SPRAVATO.”

Which Residents, and When

Ketamine isn’t a medication for opioid use disorder, so it does nothing toward the Section 23(H)(2) access duty. We’d look at it for a resident whose depression or PTSD symptoms have outlasted an adequate antidepressant trial, and only after withdrawal has settled. A history of misusing ketamine, PCP or another dissociative points the other way. Your medical director sets the actual criteria, because Maine law doesn’t.

Finishing the Course After Discharge

A stay ends long before most ketamine courses do, so the later sessions belong to an outpatient clinic. Maine has no general ban on lay ownership of health care that we could find. A 1977 Attorney General opinion said “There is no prohibition on a profit-making corporation providing health care services to citizens of the State of Maine,” though it is informal, non-binding and old. What does bind is the Professional Service Corporation Act, 13 MRS ch. 22-A: physicians and APRNs who incorporate “shall incorporate as a professional corporation,” and shares issued to anyone not qualified are “void.” In practice that points to a clinician-owned PC with a management services company handling the nonclinical side, which is our reading of how the two sources fit together. The entity and ownership details are in the ketamine section of Maine Drug and Alcohol Outpatient Treatment Licensing. A resident admitted chiefly for a psychiatric condition is a different licensing question, taken up in Maine Mental Health Inpatient Licensing.

Have a lawyer look at any payment that flows between your residential program and the outpatient clinic before it starts. The federal Eliminating Kickbacks in Recovery Act, 18 U.S.C. §220, reaches a non-hospital “clinical treatment facility” licensed or certified by the state, which in our reading includes a Chapter 123 residential SUD program, and every occurrence can draw a fine of as much as $200,000, a prison term as long as 10 years, or both. We did not find a Maine patient brokering statute. Maine’s practitioner self-referral law, 22 MRS §2085, is the closest state rule, and it limits referrals to a facility a practitioner has invested in unless that practitioner “directly provides health services within the facility.”

Who a Maine Residential Program Has to Employ

Chapter 123 builds the roster in layers. A medical director is mandatory for any SUD program beyond a community-support-only one, and the program has to employ Certified Clinical Supervisors or contract for them, with at least one who can supervise co-occurring care (Section 23(D)). A residential site needs an on-site facility or program manager (Section 21(A)), staff coverage 24 hours a day including weekends (Section 23(H)(3)(e)), and “at least one CPR-trained staff” on site around the clock (Section 21(F)(2)(b)). Each clinician gets individual supervision at least an hour a month, in person, by phone or by video, and staff who aren’t licensed to practice independently and carry 20 or more direct-service hours a week get at least four hours a month (Section 13(H)). Residents must receive at least 14 hours of counseling a week, or 2 hours a day (Section 23(H)(3)(c)).

BLS puts Maine’s median pay for substance abuse, behavioral disorder, and mental health counselors at $59,970 a year (OEWS, May 2025), with the 25th percentile at $48,090 and the 75th at $73,410, a shade above the national median of $59,350. Put a clinical director, a Certified Clinical Supervisor and three counselors on payroll at the Maine median and the five salaries total roughly $299,850 a year, or roughly $367,050 if every one sits at the 75th percentile, and that’s before nursing, overnight staff and benefits. You don’t have to fill every one of those seats with a fully licensed counselor. Maine’s counselor law, 32 MRS ch. 81, and the Board’s licensing page set a ladder: an aide can’t work without a supervision agreement on file, a certified alcohol and drug counselor practices within an agency under a certified clinical supervisor, and a licensed alcohol and drug counselor, who may practice independently, usually qualifies after 2,000 hours of supervised work as a certified counselor and an exam. A Certified Clinical Supervisor overseeing several certified alcohol and drug counselors who are building those hours toward licensure, at wages below an LADC’s, tends to run 40 to 60 percent cheaper on the clinical line than a roster made up entirely of LADCs. One limit to plan around is Section 13(J). Before an SUD clinician who isn’t a Certified Clinical Supervisor can be hired, they need a full year of clinical experience in substance use treatment plus 60 or more hours of alcohol and drug coursework within the last five years, so recruit counselors who already have that year behind them. For nursing, a single RN overseeing a handful of LPNs is usually a cheaper build than RNs on every shift. The final headcount follows from the modules you hold and the beds you license, and we can work it out with you from there.

Accreditation and How Often DLC Comes Back

Maine writes deemed status into statute. Under 5 MRS §20024, a treatment program that “receives and maintains accreditation from a national accrediting body” approved by the department “must be deemed in compliance with comparable state licensing rules” once it submits written evidence of that compliance. Chapter 123 Section 2(M) names the approved bodies: The Joint Commission, the Council on Accreditation (COA), CARF International, and “Other Department-approved national accrediting organizations.”

The rule narrows it in ways that matter for a new program. Deeming is available to “accredited organizations that have been issued a full license,” so it does nothing during the provisional term. It covers “specific provisions” of the rule, not the whole license, and DLC “may issue a written determination” on the request. The accreditation must be “without any limitation or condition,” a physical copy of the accreditor’s standards has to stay on site with the matching Chapter 123 standards identified, and DLC has to hear in writing “within 10 business days” about any shift in accreditation status, new survey findings, citations or corrective action the accreditor requires.

Routine state monitoring now happens “at least once every 2 years” under 34-B MRS §1203-A(5). That interval replaced annual monitoring through Public Law 2025, chapter 305 (LD 1961), which was approved June 12, 2025 and took effect September 24, 2025, the general effective date for that session’s non-emergency laws.

How to Submit Your Maine Residential SUD Application

The filing steps here come from the Behavioral Health Program’s own page.

The DLC Behavioral Health Program page lists the Substance Use Disorder Treatment Agency Initial, Renewal, and Change Application (Rev 9/2026). The same page says licenses “are not currently integrated,” so a program that also treats mental health conditions files the Mental Health Agency application as well and ends up holding two licenses. The page has no online portal. You email the application and every supporting document to BehavioralHealth.DLC@maine.gov, then put the fee in the mail, as a check or money order to “Treasurer, State of Maine” clipped to page one of the application, addressed to Division of Licensing and Certification, ATTN: Behavioral Health Program, 41 Anthony Ave., Augusta, ME 04330. Call (207) 287-9300, Option 2, with questions about the packet.

Section 2(E) spells out what a first application carries: an organizational chart, the governing authority and its members, a staff roster, a sample client file, the services, sites and independent contractors, a policy attestation, a floor plan showing bedroom space, an emergency and evacuation plan, a close-of-business plan with evidence of a bond or other financial instrument for close-out costs, and a municipal official’s sign-off on local codes for each site. Copies of the MaineCare and OBH notice letters go in too, and the Fire Marshal certification has to be in hand before a license issues. If the file sits incomplete for 60 calendar days after DLC receives it, the application becomes void (Section 2(D)(2)). The rule gives no deadline for DLC’s decision, and our own planning range for a residential program is six to nine months from first letters to provisional license.

Where Maine Residential Files Stall

From what we’ve seen, the close-of-business plan surprises people most, because the bond or financial instrument behind it has to be arranged before licensing, not after. Older buildings also tend to slow down at the Fire Marshal stage. Policies copied from the pre-2024 rule are a quieter problem. Chapter 5 of 14-118 CMR is repealed, and a manual still citing it tells the reviewer it wasn’t written for Chapter 123.

Frequently Asked Questions

Lining up the notice letters and Fire Marshal visit for a Maine residential site? Get in touch.

Sources

• Maine DHHS, Division of Licensing and Certification: Behavioral Health Program (application forms, submission, contact) (checked October 13, 2026)
• 10-144 CMR Ch. 123 via Cornell LII (verbatim mirror): Purpose and Applicability, Section 1, Section 2, Section 3, Section 13, Section 21, Section 23, Appendix A (checked October 13, 2026)
• Maine DHHS bulletin: Chapter 123 effective February 11, 2024 (checked October 13, 2026)
• Maine DHHS: Chapter 123 rulemaking page (rules repealed and replaced) (checked October 13, 2026)
• 22 MRS ch. 1667, §8001: Drug Treatment Centers (PDF) (checked October 13, 2026)
• 5 MRS §20024: Licensing and inspection of treatment facilities, deemed status (checked October 13, 2026)
• 34-B MRS §1203-A: Licenses, monitoring at least once every 2 years (checked October 13, 2026)
• Maine Legislature: PL 2025, c. 305 (LD 1961), chaptered text (checked October 13, 2026)
• Office of Policy and Legal Analysis: Legislative Digest, 132nd First Regular and First Special Sessions (effective dates) (checked October 13, 2026)
• 32 MRS §6203-A: Alcohol and drug counselor definitions and 32 MRS ch. 81 index (checked October 13, 2026)
• Maine Board of Alcohol & Drug Counselors: Licensing and forms (checked October 13, 2026)
• BLS OEWS, May 2025, SOC 21-1018: Occupational Employment and Wage Statistics tables (checked October 13, 2026)
• CARF: ASAM Level of Care Certification (checked October 13, 2026)
• ASAM: Level of Care Certification (checked October 13, 2026)
• CARF: Find a Provider (Certification filter) (checked October 13, 2026)
• DEA Diversion Control Division: Dear Registrant letter, January 12, 2023 (PDF) (checked October 13, 2026)
• SAMHSA: Decisions in Recovery, naltrexone and Naltrexone (checked October 13, 2026)
• Maine State Board of Nursing: Practice questions related to registered professional nurses (checked October 13, 2026)
• 32 MRS §2102: Nursing definitions, nurse practitioner 24-month supervision (checked October 13, 2026)
• Maine Drug Enforcement Agency: FAQ (no state practitioner registration) (checked October 13, 2026)
• 22 MRS ch. 1603: Prescription Monitoring Program (PDF) (checked October 13, 2026)
• 14-118 CMR Ch. 11 §5 via Cornell LII (verbatim mirror): PMP reporting and prescriber checks (checked October 13, 2026)
• 21 CFR 1308.13 via Cornell LII (verbatim mirror): Schedule III, ketamine (checked October 13, 2026)
• U.S. FDA: Spravato prescribing information and Medication Guide (checked October 13, 2026)
• Maine Attorney General opinion, March 24, 1977: Employment of physicians by corporations (PDF) (checked October 13, 2026)
• 13 MRS ch. 22-A: Maine Professional Service Corporation Act (PDF) (checked October 13, 2026)
• 18 U.S.C. §220 via Cornell LII: Illegal remunerations for referrals to recovery homes, clinical treatment facilities, and laboratories (checked October 13, 2026)
• 22 MRS §2085: Prohibited referrals and claims for payment (checked October 13, 2026)